GWS
MYGN icon

Glassman Wealth Services’s Myriad Genetics MYGN Stock Holding History

Glassman Wealth Services’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-61
Closed -$1.17K – 1211
2023
Q4 		$1.17K Sell
61
-4
-6% -$69 ﹤0.01% 1494
2023
Q3 		$1.04K Hold
65
– – ﹤0.01% 1533
2023
Q2 		$1.51K Hold
65
– – ﹤0.01% 1333
2023
Q1 		$1.51K Hold
65
– – ﹤0.01% 1324
2022
Q4 		$943 Sell
65
-19
-23% -$354 ﹤0.01% 1439
2022
Q3 		$2K Hold
84
– – ﹤0.01% 1240
2022
Q2 		$2K Hold
84
– – ﹤0.01% 1261
2022
Q1 		$2K Hold
84
– – ﹤0.01% 1246
2021
Q4 		$2K Buy
+84
New +$2.43K ﹤0.01% 1218

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Glassman Wealth Services's MYGN Position: Q1 2024 in Review

Glassman Wealth Services sold out of Myriad Genetics (MYGN) in Q1 2024, closing a stake of 61 shares — an estimated $1.17K sold.

Glassman Wealth Services first reported a position in MYGN in Q4 2021 and held it in 9 quarters. The position peaked at $2K in Q3 2022. 186 funds tracked by Wall St. Rank hold MYGN as of Q1 2024.

  • Glassman Wealth Services reported no remaining Myriad Genetics position as of Q1 2024 after selling out during the quarter.
  • Glassman Wealth Services sold 61 Myriad Genetics shares in Q1 2024, an estimated $1.17K.
  • Glassman Wealth Services first reported a position in Myriad Genetics in Q4 2021 and held it in 9 quarters.
  • Glassman Wealth Services's Myriad Genetics position peaked at $2K in Q3 2022.
  • 186 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.